Global Nanopore Sequencing Market Size & Trends Report Segmented by Product (Instruments, Consumables), Type of Nanopore (Solid State, Biological, Hybrid), Type of Nucleotide Sequenced (DNA, RNA), Application, End-user & Regional Forecast to 2030
The nanopore sequencing market is expected to grow at a CAGR of approximately 11% during the forecast period, which is primarily driven by the increasing demand for real-time and field-portable DNA sequencing technology, especially in infectious disease studies and clinical diagnostics. However, the market may be hindered due to higher error rates in this sequencing and lack of standardization protocols for sample preparation. To learn more about the research report, download a sample report.
Report Overview
Nanopore sequencing is a DNA sequencing technique that interprets genetic material by detecting alterations in electric current when strands of DNA or RNA pass through a protein pore inserted within a membrane. In contrast to conventional sequencing platforms, the process does not need amplification or labeling of nucleic acid. It supports long-read sequencing in real time and is particularly important for the discovery of structural variants and complex genomic rearrangements. Its portability and flexibility have expanded new avenues across areas from environment monitoring to rapid pathogen identification in remote settings.
To learn more about this report, download the PDF brochure
Real-time diagnostics fuel adoption of portable nanopore sequencing
The increasing adoption of nanopore sequencing in clinical diagnostics and infectious disease monitoring is the primary factor driving market growth. Its capacity to deliver fast, real-time genomic information in near-patient environments is radically changing the way diseases are identified and tracked. During outbreaks such as COVID-19 and antimicrobial resistance, the portability and speed of nanopore devices enabled scientists and health officials to conduct field-based genetic sequencing, unlike with cumbersome laboratory-based platforms. This field suitability has not just accelerated the timeframe to actionable answers but has also democratized access to genomic information in resource-poor settings. Additionally, clinicians can now track viral mutations and trends in bacterial resistance more nimbly, and this means more accurate and timely interventions. With healthcare trending towards advancements in personalized medicine and rapid diagnostics, the practical usefulness of nanopore sequencing is becoming increasingly clear, with a firm foundation in both day-to-day clinical labs and global health initiatives.
To learn more about this report, download the PDF brochure
Biochemical upgrades drive precision in nanopore sequencing tools
One of the key innovations that has improved the performance and reliability of nanopore sequencing is the creation of R10 nanopores. In contrast to previous generations, R10 nanopores have dual reader heads that enhance the resolution of DNA strand detection, particularly in challenging areas such as homopolymers. This has had a direct impact on improved consensus accuracy, solving one of the most quoted limitations of the technology. In addition to these advances, improvements in motor proteins that regulate the rate at which DNA is passed through the pore have notably enhanced signal stability and readability. These innovations are essential since they enable researchers to obtain more consistent results without compromising on the fundamental advantage of portability and the ability to produce long reads. By focusing on the biochemical mechanics of sequencing rather than computation-based solutions to these problems, these innovations make the technology robust, broadening its appeal for research and diagnostic uses that require greater accuracy.
Competitive Landscape Analysis
The global nanopore sequencing market is marked by the presence of established and emerging market players such as QIAGEN, Oxford Nanopore Technologies Limited, Eurofins Scientific, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Danaher Corporation, PerkinElmer Inc., Thermo Fisher Scientific, Pacific Biosciences, and Myriad Genetics, Inc. among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 – 2030 |
| Growth Rate | 11% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Product, Type of Nanopore, Type of Nucleotide Sequenced, Application and End-user |
| Regional Scope |
|
| Key Companies Mapped | Pacific Biosciences, Oxford Nanopore Technologies Limited QIAGEN, Eurofins Scientific, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Danaher Corporation, PerkinElmer Inc., Thermo Fisher Scientific, and Myriad Genetics, Inc., among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Nanopore Sequencing Market Segmentation
This report by Medi-Tech Insights provides the size of the global nanopore sequencing market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, type of nanopore, type of nucleotide sequenced, application and end-user.
Market Size & Forecast (2023-2030), By Product, USD Million
- Instruments
- Consumables
Market Size & Forecast (2023-2030), By Type of Nanopore, USD Million
- Solid State
- Biological
- Hybrid
Market Size & Forecast (2023-2030), By Type of Nucleotide Sequenced, USD Million
- DNA
- RNA
Market Size & Forecast (2023-2030), By Application, USD Million
- Human Genetics
- Clinical Research
- Animal Research
- Others
Market Size & Forecast (2023-2030), By End-user, USD Million
- Biotechnological Companies
- Clinical Laboratories
- Academic & Research Institutes
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the nanopore sequencing market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the nanopore sequencing market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Nanopore Sequencing Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Growing use in real-time infectious disease surveillance
- Demand for portable, field-deployable sequencing tools
- Rising adoption in cancer and rare disease diagnostics
- Ability to sequence long reads without amplification
- Expansion into agricultural and environmental genomics
- Increased funding for genomics research in both developed and emerging markets
- Restraints
- Higher error rates compared to other sequencing methods
- Lack of standardized protocols across labs
- Limited awareness and training among clinical practitioners
- Opportunities
- Growing preference for real-time sequencing data
- Shift towards decentralized genomics platforms across clinical labs
- Rising investments from private and public sectors in portable sequencing tools
- Key Market Trends
- Refinement in nanopore and enzyme designs
- Increased interest in hybrid sequencing approaches
- Unmet Market Needs
- Industry Speaks
- Drivers
- Market Dynamics
- Global Nanopore Sequencing Market Size & Forecast (2023-2030), By Product, USD Million
- Introduction
- Instruments
- Consumables
- Global Nanopore Sequencing Market Size & Forecast (2023-2030), By Type of Nanopore, USD Million
- Introduction
- Solid State
- Biological
- Hybrid
- Global Nanopore Sequencing Market Size & Forecast (2023-2030), By Type of Nucleotide Sequenced, USD Million
- Introduction
- DNA
- RNA
- Global Nanopore Sequencing Market Size & Forecast (2023-2030), By Application, USD Million
- Introduction
- Human Genetics
- Clinical Research
- Animal Research
- Others
- Global Nanopore Sequencing Market Size & Forecast (2023-2030), By End-user, USD Million
- Introduction
- Biotechnological Companies
- Clinical Laboratories
- Academic & Research Institutes
- Others
- Global Nanopore Sequencing Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Nanopore Sequencing Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type of Nanopore (USD Million)
- Market Size & Forecast, By Type of Nucleotide Sequenced (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Canada
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type of Nanopore (USD Million)
- Market Size & Forecast, By Type of Nucleotide Sequenced (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- US
- Europe Nanopore Sequencing Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type of Nanopore (USD Million)
- Market Size & Forecast, By Type of Nucleotide Sequenced (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Germany
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type of Nanopore (USD Million)
- Market Size & Forecast, By Type of Nucleotide Sequenced (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- France
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type of Nanopore (USD Million)
- Market Size & Forecast, By Type of Nucleotide Sequenced (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Italy
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type of Nanopore (USD Million)
- Market Size & Forecast, By Type of Nucleotide Sequenced (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Spain
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type of Nanopore (USD Million)
- Market Size & Forecast, By Nucleotide Sequenced (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Europe
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type of Nanopore (USD Million)
- Market Size & Forecast, By Nucleotide Sequenced (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- UK
- Asia Pacific (APAC) Nanopore Sequencing Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type of Nanopore (USD Million)
- Market Size & Forecast, By Type of Nucleotide Sequenced (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Japan
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type of Nanopore (USD Million)
- Market Size & Forecast, By Type of Nucleotide Sequenced (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- India
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type of Nanopore (USD Million)
- Market Size & Forecast, By Type of Nucleotide Sequenced (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type of Nanopore (USD Million)
- Market Size & Forecast, By Type of Nucleotide Sequenced (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- China
- Latin America (LATAM) Nanopore Sequencing Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type of Nanopore (USD Million)
- Market Size & Forecast, By Type of Nucleotide Sequenced (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Middle East & Africa (MEA) Nanopore Sequencing Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type of Nanopore (USD Million)
- Market Size & Forecast, By Type of Nucleotide Sequenced (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launch/Approval
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Pacific Biosciences
- Oxford Nanopore Technologies Limited
- QIAGEN
- Eurofins Scientific
- Agilent Technologies, Inc.
- Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- PerkinElmer Inc.
- Thermo Fisher Scientific
- Myriad Genetics, Inc
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Biotechnological Companies, Clinical Laboratories, Academic & Research Institutes and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
